Call on SAMHSA to help ensure that the regulatory framework for medications for opioid use disorder treatment continues to accommodate evolving practice models that deliver treatment services in new and innovative ways – and in different patient care settings.
A White House ceremony on Tuesday marked the end of the “X-waiver” requirement.
Comments to Centers for Medicare & Medicaid Services call for enforcement of electronic prescribing of controlled substances requirements no later than January 1, 2023.
Legislation would help reduce drug abuse and misuse by continuing to advance electronic prescribing.
Virtual event brings together traditional drug and grocery chains with between four and 250 locations, and their supplier partners; features insights and collaboration on diverse health-and-wellness and front-end topics.
Goal is careful use of prescription opioids and reduction of quantity of unused controlled substances that could be diverted or abused.
A letter to Congress asks that the Centers for Medicare & Medicaid Services "promptly undertakes the requisite rulemaking so that the agency is able to establish a January 1, 2022 deadline for EPCS compliance” to help address opioid-abuse issues.
NACDS is urging the DEA to make electronic prescriptions for controlled substances (EPCS) mandatory.
The State of Maryland has taken another important step forward to enhance the security of controlled-substances prescriptions and to reduce the likelihood of fraudulent prescribing.
